Entrada Therapeutics Inc (TRDA) USD0.0001
Sell:$12.41Buy:$14.65
$0.88
(6.58%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$12.41
Buy:$14.65
Change:$0.88
(6.58%)
$0.88
(6.58%)Prices delayed by at least 15 minutes
Sell:$12.41
Buy:$14.65
Change:$0.88
(6.58%)
$0.88
(6.58%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 December 2024 | MPM BIOVENTURES 2018 LPVenture Capital | Sell Regular sell transaction (market) | 21,787 | $20.23 | $440,751.01 | 4,381,062 |
| 10 December 2024 | MPM BIOVENTURES 2018 LPVenture Capital | Sell Regular sell transaction (market) | 22,935 | $20.77 | $476,359.95 | 4,402,849 |
| 3 December 2024 | Natarajan SethuramanOther President | Sell Regular sell transaction (market) | 11,703 | $20.15 | $235,786.19 | 144,997 |
| 2 December 2024 | Natarajan SethuramanOther President | Sell Regular sell transaction (market) | 4,088 | $20.26 | $82,833.51 | 156,700 |
| 2 December 2024 | Kory James WentworthCFO | Sell Option/Award related | 5,000 | $20.00 | $99,978.00 | 73,849 |
| 29 November 2024 | Natarajan SethuramanOther President | Sell Regular sell transaction (market) | 100 | $20.00 | $2,000.00 | 160,788 |
| 29 November 2024 | Kory James WentworthCFO | Sell Option/Award related | 1,000 | $19.97 | $19,970.30 | 73,849 |
| 13 November 2024 | Natarajan SethuramanOther President | Sell Regular sell transaction (market) | 2,700 | $20.04 | $54,108.81 | 160,888 |
| 11 November 2024 | Natarajan SethuramanOther President | Sell Regular sell transaction (market) | 1,409 | $20.01 | $28,191.13 | 163,588 |
| 11 November 2024 | Kory James WentworthCFO | Sell Regular sell transaction (market) | 8,637 | $19.98 | $172,562.08 | 73,849 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 25 June 2024 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 3,081,303 | $14.85 | $45,757,041.42 | 3,081,303 |
| 25 June 2024 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 285,700 | $14.85 | $4,242,616.43 | 285,700 |
| 10 December 2024 | MPM BIOVENTURES 2018 LPVenture Capital | Sell Regular sell transaction (market) | 22,935 | $20.77 | $476,359.95 | 4,402,849 |
| 11 December 2024 | MPM BIOVENTURES 2018 LPVenture Capital | Sell Regular sell transaction (market) | 21,787 | $20.23 | $440,751.01 | 4,381,062 |
| 16 August 2024 | Nathan J DowdenPresident/COO | Sell Regular sell transaction (market) | 26,595 | $16.26 | $432,418.74 | 130,609 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.